Co-Authors
This is a "connection" page, showing publications co-authored by Gokhan M. Mutlu and Lucas Kimmig.
Connection Strength
2.431
-
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections. Front Med (Lausanne). 2020; 7:583897.
Score: 0.761
-
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. medRxiv. 2020 Sep 12.
Score: 0.755
-
TGF-ß Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation. Am J Respir Cell Mol Biol. 2020 11; 63(5):601-612.
Score: 0.190
-
Late onset infectious complications and safety of tocilizumab in the management of COVID-19. J Med Virol. 2021 03; 93(3):1459-1464.
Score: 0.188
-
Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response. Elife. 2020 04 07; 9.
Score: 0.183
-
Tissue-Resident Alveolar Macrophages Do Not Rely on Glycolysis for LPS-induced Inflammation. Am J Respir Cell Mol Biol. 2020 02; 62(2):243-255.
Score: 0.181
-
Update in Chronic Obstructive Pulmonary Disease 2018. Am J Respir Crit Care Med. 2019 06 15; 199(12):1462-1470.
Score: 0.173